Ablative Therapy for Esophageal Dysplasia and Early Malignancy : Focus on RFA
Joint Authors
Hochwald, Steven N.
Nurkin, Steven J.
Tuttle, Rebecca
Source
Issue
Vol. 2014, Issue 2014 (31 Dec. 2014), pp.1-10, 10 p.
Publisher
Hindawi Publishing Corporation
Publication Date
2014-07-21
Country of Publication
Egypt
No. of Pages
10
Main Subjects
Abstract EN
Ablative therapies have been utilized with increasing frequency for the treatment of Barrett’s esophagus with and without dysplasia.
Multiple modalities are available for topical ablation of the esophagus, but radiofrequency ablation (RFA) remains the most commonly used.
There have been significant advances in technique since the introduction of RFA.
The aim of this paper is to review the indications, techniques, outcomes, and most common complications following esophageal ablation with RFA.
American Psychological Association (APA)
Tuttle, Rebecca& Nurkin, Steven J.& Hochwald, Steven N.. 2014. Ablative Therapy for Esophageal Dysplasia and Early Malignancy : Focus on RFA. BioMed Research International،Vol. 2014, no. 2014, pp.1-10.
https://search.emarefa.net/detail/BIM-487568
Modern Language Association (MLA)
Tuttle, Rebecca…[et al.]. Ablative Therapy for Esophageal Dysplasia and Early Malignancy : Focus on RFA. BioMed Research International No. 2014 (2014), pp.1-10.
https://search.emarefa.net/detail/BIM-487568
American Medical Association (AMA)
Tuttle, Rebecca& Nurkin, Steven J.& Hochwald, Steven N.. Ablative Therapy for Esophageal Dysplasia and Early Malignancy : Focus on RFA. BioMed Research International. 2014. Vol. 2014, no. 2014, pp.1-10.
https://search.emarefa.net/detail/BIM-487568
Data Type
Journal Articles
Language
English
Notes
Includes bibliographical references
Record ID
BIM-487568